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Abstract: Many intriguing facets of lipoxygenase (LOX) catalysis are open to a detailed structural
analysis. Polyunsaturated fatty acids with two to six double bonds are oxygenated precisely on a
particular carbon, typically forming a single chiral fatty acid hydroperoxide product. Molecular oxy-
gen is not bound or liganded during catalysis, yet it is directed precisely to one position and one
stereo configuration on the reacting fatty acid. The transformations proceed upon exposure of sub-
strate to enzyme in the presence of O2 (RH 1 O2 fi ROOH), so it has proved challenging to capture
the precise mode of substrate binding in the LOX active site. Beginning with crystal structures with
bound inhibitors or surrogate substrates, and most recently arachidonic acid bound under anaero-
bic conditions, a picture is consolidating of catalysis in a U-shaped fatty acid binding channel in
which individual LOX enzymes use distinct amino acids to control the head-to-tail orientation of
the fatty acid and register of the selected pentadiene opposite the non-heme iron, suitably posi-
tioned for the initial stereoselective hydrogen abstraction and subsequent reaction with O2. Draw-
ing on the crystal structures available currently, this review features the roles of the N-terminal b-
barrel (C2-like, or PLAT domain) in substrate acquisition and sensitivity to cellular calcium, and the
a-helical catalytic domain in fatty acid binding and reactions with O2 that produce hydroperoxide
products with regio and stereospecificity. LOX structures combine to explain how similar enzymes
with conserved catalytic machinery differ in product, but not substrate, specificities.
Keywords: lipoxygenase; polyunsaturated fatty acids; linoleic acid; arachidonic acid; hydroperoxide
oxygenation; oxylipins
Introduction
Lipoxygenase (LOX) enzymes are widely expressed
in animals, plants, and fungi, and although also
ubiquitous in cyanobacteria, LOX enzymes are quite
rarely found in other prokaryotes.1 The specificities
of their reactions provide fatty acid hydroperoxides
with differing functional roles. LOX reactions com-
monly initiate pathways of lipid mediator biosynthe-
sis,2,3 they are used for the mobilization of lipids for
energy production or for structural roles4,5 and the
hydroperoxide products possibly ramp up cellular
peroxide tone, potentially with an activating effect
on other pathways.6,7 With respect to nomenclature,
mammalian 5-lipoxygenase oxygenates carbon-5 on
arachidonic acid, a plant 13-LOX oxygenates the 13-
carbon of linoleic or a-linolenic acids, and so on.
LOX catalysis is always centered around a five-
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carbon unit with a CH2 methylene between a pair of
cis double bonds (CH@CHACH2ACH@CH). Molecu-
lar oxygen is introduced at one end or other of the
pentadiene (regiospecificity), and in either the R or
S configuration (stereospecificity). The reaction of
fatty acid with O2 is covalently complete (RH 1 O2
! ROOH) and, therefore, no reducing cofactor is
required.
The specificity with which LOX enzymes (1)
oxygenate polyunsaturated fatty acids raises intrigu-
ing questions for the structural biologist on how
these reactions are initiated and controlled. The typ-
ical LOX product is a single, chiral, fatty acid hydro-
peroxide (Scheme 18). Remarkably there is a LOX
enzyme specific for most of the available positions
on the common substrates, linoleic and arachidonic
acids. LOX enzymes are known that oxygenate lino-
leic acid at three of its four available positions (9R,
9S, or 13S),9 and there are LOX enzymes specific for
10 of the 12 available positions on arachidonic acid
(5R, 5S, 8R, 8S, 9R, 11R, 11S, 12R, 12S, and 15S
are all known in Nature.1,10,11 The conceptual basis
for this specificity is quite well established (see
later), yet the structural basis remains an open
issue. With the availability of genomic sequences
providing any of these enzymes open for cloning and
expression, the wealth of diversity provides opportu-
nities for the structural biologist to compare and
contrast enzymes with a view to explaining the dis-
tinct catalytic specificities.
The first section of this review explains the
chemistry of the LOX reaction and the conceptual
basis of specificity, the next provides an overview of
LOX enzyme structure. It then details our current
understanding of structure and function.
The Conceptual Basis of Specificity
LOX enzymes initiate, control, and terminate a free
radical reaction between the substrate fatty acid
and molecular oxygen. The non-heme iron initiates
the reaction by stereoselective H-abstraction on one
face of the fatty acid and then oxygen reacts on the
opposite face, an antarafacial relationship common
to all LOX catalysis.12 A major element of stereo
control is inherent in this antarafacial “rule” but
with so many distinct hydroperoxide products ema-
nating from LOX active sites of very similar overall
structure, the basis of specificity has to include
(i) the precise positioning of the fatty acid carbon
chain in the active site, (ii) the head-to-tail orienta-
tion of the fatty acid, and (iii) the access of molecu-
lar oxygen to one end or other of the reacting
pentadiene.
Point (i) involves a “frame-shift” as the fatty
acid can slide to different depths into the active site
and expose a selected pentadiene for reaction with
the iron.13 For example, the difference between 12-S
and 15-S oxygenation of arachidonic acid involves
this shift in the register of substrate.14 Point (ii),
switching of the head-to-tail orientation of the fatty
acid in the active site, was first deduced in the early
1970s from the finding that plant 9S-LOX and 13S-
LOX abstract the 11pro-R and 11pro-S hydrogen,
respectively, from linoleic acid.15 As illustrated in
Figure 1, the 9S and 13S positions are on opposite
faces of linoleic acid, and therefore a logical deduc-
tion is that regio and stereo control is equivalent in
all respects except that the linoleate substrate is
turned around in a switched head-to-tail orientation
in the two enzymes. This was a logical deduction at
the time, although there was no information on the
relatedness of the two enzymes. Now we know of the
close structural homology within the LOX gene fam-
ily and it is a compelling argument, and the only
reasonable explanation for the many known LOX
Figure 1. The basis of LOX regio- and stereospecificity.
(A)The structures of linoleic acid (18:2) and arachidonic acid
(20:4). (B) A perspective view on LOX catalysis showing the
reacting pentadiene. Top left: The catalytic iron (Fe-OH)
abstracts the pro-R hydrogen from C11 and O2 is added
antarafacially in the 9S position (in red, in the foreground).15
Lower left: with linoleic acid in a reversed head-to-tail orien-
tation, the identical stereochemical relationships involve pro-
S hydrogen abstraction at C11 and oxygenation in the 13S
position (in red, in the foreground).15 Formation of the corre-
sponding 9R or 13R configuration products entails antarafa-
cial reaction of O2 at the opposite end of the pentadiene.
16 In
boxes on the right side: an example of the corresponding
positional specificities of arachidonic acid, illustrating the
positions around the 8–12 pentadiene on arachidonic acid.
Scheme 1. Lipoxygenase catalysis.
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reactions with arachidonic acid. This is especially
the case when we know that stereospecific 15S-
HPETE synthesis can be followed by 5S or 8S oxy-
genation in the reversed orientation in the same
LOX active site.8 Point (iii), the access of O2 to one
end or other of the reacting pentadiene, is the ulti-
mate determinant of R or S specificity. As illustrated
in Figure 1, the R and S positions are at opposite
ends on each face the pentadiene. Also shown in Fig-
ure 1, oxygenations occurring on the same face of
the substrate (e.g., 9S/13R or 9R/13S) are initiated
by the same stereospecific hydrogen abstraction.16
Mutagenesis studies reveal the importance of an Ala
residue conserved in S-LOX and the equivalent Gly
residue in R-LOX,17 yet how this comes into play is
a structural issue waiting to be solved. Selective
shielding of one end or the other of the pentadiene
and directional channeling of O2 have both been
proposed.18–22
Lipoxygenase Structure
In 1993, Boyington et al.23 described the first crystal
structure of a LOX, the L1 isoform from Soybean.
This structure established the molecular framework
common to plant and animal enzymes: an amino ter-
minal b-barrel, now known as a PLAT (Polycystin-1,
Lipoxygenase, Alpha-Toxin) domain and a much
larger a-helical domain that houses the catalytic
iron. The plant enzymes are significantly larger
than the animal enzymes (900 vs. 650 amino
acids, respectively), and the smaller animal enzymes
are simply pared down by the omission of several
plant-specific loop regions. More recently, the struc-
ture of a LOX from the opportunistic pathogen P.
aeruginosa has been reported.24 This enzyme is
reduced further still: it lacks the amino terminal b-
barrel domain. However, an a-helical insertion
expands the catalytic domain and an additional
amino terminal helix shields the surface covered by
the PLAT domain of the eukaryotic enzymes.
Despite these differences, a large helical core, along
with the relative placements of most of the 17 heli-
ces that comprise it, is conserved (Fig. 2). At the
heart of the core is the catalytic iron, positioned by
invariant histidine side chains contributed by the
two longest helices in the common core (40–50
amino acids in length, helices a7 and a14 (green,
orange, respectively, Fig. 3), as well as the main
chain carboxyl at the C-terminus provided by an
invariant Ile. On the opposite side of the iron are
helix a8 (lime-green) and the penultimate (red)
helix. An unusual structural feature of helix a8, a
unique insertion which gives it a distinct curva-
ture,25 has been observed in all LOX structures to
date (bright pink, Fig. 2). This helix, subsequently
referred to as the “arched” helix, helps shield a
Figure 2. The common core of LOXs is shared by plant, animal and bacterial enzymes. (A) The core domain is a large bundle
of helices that houses the catalytic iron. A distinct insertion that contributes to a helix that forms an arch over the active site is
colored in bright pink. (B) and (C) The animal (flesh) and plant (green) enzymes have amino terminal domain PLAT domains that
may harbor Ca21 binding sites. (D) The bacterial LOX lacks the PLAT domain, but has additional helices. An interactive view is
available in the electronic version of the article.
This figure also includes an iMolecules 3D interactive version that can be accessed via the link at the bottom of this figure’s caption.
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U-shaped cavity, at the base of which lies the cata-
lytic center. The remainder of the common core is an
awkward bundling of helices, primarily in antiparal-
lel orientations. The protein data bank codes for the
four plant,23,25–27 seven animal,28–34 and single bac-
terial enzyme24 are given in Table I.
The Carboxy Terminus Fills the Iron
Coordination Sphere
The iron coordination sphere adopts a pseudo octa-
hedral geometry.35 A remarkable feature of the coor-
dination sphere is the utilization of the main-chain
carboxy-terminus as an iron ligand (Fig. 4). In order
for the main-chain carboxyl to fill the sphere the ter-
minal Ile must insert into the helical bundle to posi-
tion itself at the iron, deep in the four-helix bundle.
The insertion is made possible by irregularities in
the helices that form the core. While the inserted
peptide fills what would otherwise be a gaping hole
in the helical bundle, it does not fill it completely,
and in the high resolution structure of P. homomalla
8R-LOX an intricate network of water molecules sol-
vates the “buried” C-terminus, including the termi-
nal Ile side chain (Fig. 4). A similar solvent channel
is apparent in the 1.4 Å resolution structure of Soy-
bean LOX1.25 The majority of the hydrogen bonds
Figure 3. Four helices form the heart of the common core structure (depicted in 8R-LOX). Amino acids from these helices con-
tribute the major part of the side chains that form the iron binding site and substrate binding cavity. (A) The location of these four
helices in the LOX overall structure. (B) The amino acids that form the arachidonic acid binding site in 8R, colored accordingly.
(C) and (D) Details of the helical core with 90 rotation so that the cavity entrance can be visualized. An interactive view is avail-
able in the electronic version of the article.
Table I. LOX Structures in the Protein Data Bank
Lipoxygenase PDB codes Inhibitor/substrate structures Resolution (Å) References
Glycine max LOX1 2SBL/1YGE — 2.6/1.4 23,25
Glycine max LOX3 1LNH 1IK3, 1HU9, 1NO3, IN8Q, 1JNQ, 1ROV 2.6 26,48
Glycine max LOXB 2IUJ — 2.4 27
Glycine max LOXD 2IUK — 2.4 27
O. cuniculus 15-LOX-1 1LOX/2P0M 1LOX/2P0M 2.4 28,29
P. homomalla 8R-LOX 2FNQ/3FG1 4QWT 3.1/1.85/2.0 40, 41, 34
H. sapiens 5-LOX 3O8Y — 2.4 30
G. fruticosa 11R-LOX 3VF1 — 2.5 31
S. scrofa 12-LOX (truncation) 3RDE 3RDE 1.89 32
H. sapiens 15-LOX-2 4NRE 4NRE 2.63 33
H. sapiens 12-LOX (truncation) 3D3L — 2.6 —
P. aeruginosa 4G32/4G33 4G32, 4G33 1.75,2.03 24
This figure also includes an iMolecules 3D interactive version that can be accessed via the link at the bottom of this figure’s caption.
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that restrain the C-terminus in 8R-LOX are main-
chain to main-chain; however, a highly conserved
Asn four amino acids upstream of the C-terminus
participates in main-chain to main-chain, main-
chain to side-chain, and side-chain to main-chain H-
bonds. The numerous H-bonds mediated by this resi-
due are consistent with its high degree of conserva-
tion. In contrast the Ile sidechain makes limited van
der Waals contacts within the protein core and,
although “buried,” is highly solvated, and it is not
obvious why it is virtually invariant.
Variations in the Common Core
While the orientations of most of the “common core”
helices are maintained, a notable exception is helix
a2 (Fig. 5). The positioning in plants is impacted by
a plant specific insertion and it cannot occupy the
same space as its counterparts in the animal and
bacterial enzymes. Its placement occludes access to
the catalytic machinery. A putative access portal
that requires movement of the side chain in Thr-259
located on this helix, as well as Leu-541 from a
neighboring helix, was inferred from a crystal struc-
ture of LOX1.36 More recently Bradshaw and Gaff-
ney probed the dynamics of soybean LOX1 a2 by
sampling along this helix with site-directed muta-
genesis, spin-labeling and EPR. Their results, which
allow them to observe mobility along the helix at a
time scale relevant to catalysis and in the presence
of substrate, put the “portal” just a few residues up
from Thr-259 at a conserved p-helical segment of a2
at 261–267.37 Earlier work by the investigators led
them to position the polar end of the fatty acid at
the “entrance” end of the cavity.38 Their data sug-
gest a model in which the hydrocarbon region of the
substrate interacts with the p-helix segment to
grease its way between the two helices (a2 and the
arched helix) that shield the active site. The combi-
nation of dynamic EPR spin-label experiments and a
crystal structure provides a compelling model for
how substrate enters the encapsulated active site in
plant LOXs.39
In the animal enzymes three placements of a2,
which fall into two classes, have been described. The
more commonly observed a2 orientation is as a sin-
gle helix that runs almost the length of the catalytic
domain and packs against the penultimate helix of
the common core. In this orientation it rims the
active site cavity, but does not obscure access to the
active site as its counterparts do in the plant
enzymes. A variation of this orientation, in which a2
is displaced 10 Å from the commonly observed
position, is found in the rabbit 15-LOX structure in
the presence of an inhibitor. The displacement
results in significant remodeling of the active site
cavity. However, a similar displacement is not
observed in other LOX structures reported with
inhibitors that are substrate mimics32,33 or in 8R-
LOX in the presence of arachidonic acid.34 Thus, a
conformational change of such magnitude is not
required for substrate entry into the active site for
all isoforms.
Alternately, a2 has been observed as a “broken”
helix that covers the active site cavity and contrib-
utes bulky, aromatic amino acids that plug an other-
wise open U-shaped site. The “corking” aromatics
are not unique to the closed enzymes, and no
obvious sequence hallmarks, except perhaps the
presence of a small side chain (Ala), which appears
to make insertion possible, in the penultimate helix,
can be inferred from the small number of structures
Figure 4. The iron coordination sphere. (A) Superposition of
the iron ligands from representative plant (1YGE) animal
(4QWT) and bacterial (4G32) structures. (B) The C-terminal
region of the enzymes; a long loop that follows the terminal
a-helix makes its way to the catalytic iron so that the car-
boxyl can fill the coordination sphere. (C). A portion of the
electron density map for 8R-LOX (3FG1), centered around
the C-terminal Ile. Note the presence of a water-filled cavity
that accommodates the terminal Ile.
Figure 5. The placement of a2 varies among LOXs. The
“arched” helix and helix a2 in the plant (green, 1YGE) animal
(flesh, 4QWT) and bacterial enzymes (light blue, 4G32) are
superimposed. The “broken” a2 (brown, 3O8Y) of 5-LOX is
included as well for reference. Note that while the arched hel-
ices from the diverse structure superpose, a2 varies in its
placement.
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reported. The two enzymes that display this alter-
nate configuration (5S- and 11R- LOX, Ala at posi-
tions 606 and 612, respectively, Table II) share
35% identity and differ significantly in product
specificity, and both structures were determined in
the absence of inhibitor or substrate.30,31 However,
other structures in the absence of inhibitor or sub-
strate have open cavities (15-LOX-1,29 8R-LOX40,41),
with an unbroken helical structure that anchors the
“corking” aromatic amino acids far from the active
site entrance. Interestingly, the 12-LOX inhibitor,
which was necessary for crystallization of the cata-
lytic domain of that enzyme, has an aromatic ring
which occupies the same space as the “corking” side
chain common to the human and coral enzymes,32
hence “corked” and “uncorked” LOXs can accommo-
date aromatic rings at the active site entrance
(Fig. 6). This might suggest that the determining
factor for “corking” is not an aromatic amino acid in
helix a2, but whether a2 is “broken” such that its
aromatic side chain(s) are in proximity to the cavity
entrance.
The PLAT Domain and Ca21 Dependent
Membrane Binding
The amino terminal domain common to the plant and
animal LOXs was originally known as a “C2-like”
domain, given its resemblance to the Ca21-dependent
membrane binding domains of phospholipases. More-
over, like the phospholipase C2 domains, the PLAT
domains were shown to confer membrane binding,
most notably for the 5-LOX enzyme.42,43 Beyond the
fact that this domain has been demonstrated to
mediate membrane binding in experiments with






















4QWT 3FG1 3O8Y 4NRE 2P0M 3RDE 1YGE 1LNH 2IUJ 2IUK 4G32
Tyr-178 Phe-185 Phe-177 Phe-184 Phe-175 Phe-175 Ala-254 Phe-272 Phe-267 Phe-277 --
Arg-182 Gly-188 Tyr-181 Ala-188 Leu-179 Leu-179 Gly-258 Gly-276 Gly-271 Gly-281 --
Gln-380 Gln-369 Gln-363 Glu-369 Gln-357 Glu-357 Gln-495 Gln-514 Gln-509 Gln-521 Glu-373
His-384 373 367 373 361 361 499 518 513 525 377
Leu-385 374 368 374 362 362 Trp-500 Trp-519 Trp-514 Trp-526 378
His-389 378 372 378 366 366 504 523 518 530 382
Ile-423 412 406 412 400 400 538 557 552 564 I416
Gly-427 Gly-416 Ala-410 Ala-416 Ala-404 Ala-404 Ala-542 Ala-561 Ala-556 Ala-568 Ala-420
Leu-431 420 414 420 408 408 546 565 560 572 424
Ile-437 Ala-426 Leu-420 Val-426 Ile-414 Ile-414 Ile-552 Val-571 Ile-566 Ile-578 Phe-430
Val-438 Ala-427 Phe-421 Val-427 Phe-415 Phe-415 Ile-553 Ile-572 Ile-567 Ile-579 Ile-430
Leu-442 Leu-431 Asn-425 Thr-431 Met-419 Leu-419 Phe-557 Phe-576 Phe-571 Phe-583 Phe-435
Ala-589 Thr-575 Pro-569 Pro-572 Cys-560 Cys-560 Thr-709 Thr-728 Thr-723 Thr-735 Ala-574
Ala-620 Met-606 His-600 Val-603 Gln-590 Gln-590 Ser-747 Asp-766 Asp-761 Asp-773 Lys-605
Thr-623 Val-609 Ala-603 Ala-606 Ile-593 Ile-593 Val-750 Val-769 Ile-764 Ile-766 Ile-608
Ile-626 Ala-612 Ala-606 Leu-609 Gln-596 Gln-596 Ile-753 Ile-772 Ile-767 Ile-779 Leu-611
Leu-627 613 607 610 597 597 754 773 768 780 612
Overall sequence identity with P. homomalla 8R-LOX is in indicated. The amino acids of the highly conserved active site
core are in italics and shown in Bold font for reference structure.
Figure 6. The active site of animal LOXs can be “corked.” (A) The corking amino acids of 5-LOX (pink) and 11R-LOX (yellow)
plug what would otherwise be an open U-shaped cavity (15-LOX-2, flesh). (B) The corking amino acids are conserved in
“uncorked” LOXs (blue, 12-LOX, green, 15-LOX-2), however since a2 is not “broken” the side chains are distal and cannot seal
the active site entrance. The image has been rotated relative to (A) for clarity. (C) In the inhibited structure of 12-LOX an aro-
matic ring of the inhibitor (gold, OYP) occupies the position of the “cork.”
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PLAT-domain truncations, and the observation that
amino terminal truncation mutants have impaired
stability44 and reaction rates,45 a direct role for the
PLAT domain in substrate acquisition has yet to be
demonstrated. However, Eek et al. have suggested a
plausible communication pathway connecting the
PLAT Ca21-binding site with helix a2 in the 11R-LOX
enzyme via a cation-p interaction between an invari-
ant Trp of the PLAT domain with K172 of that cata-
lytic domain. A role for this cation-p interaction in
linking the LOX domains is supported by its presence
in both the plant and animal enzyme structures in
the protein data bank, and by multiple sequence
alignment.31
The PLAT domains display significantly less
sequence conservation than the catalytic domains,
notwithstanding a high degree of structural conser-
vation. Early experiments with C2-like domain con-
structs demonstrated its importance in Ca21-
dependent membrane binding for 5-LOX.42,43 How-
ever, the amino acids that coordinate Ca21 are not
highly conserved among the LOX family. Moreover
putative membrane insertion loops that emanate
from the b–barrel framework differ among
orthologs.
Crystal structures that provide insight into
Ca21 binding include that of the 8R-LOX,40 11-R-
LOX31 and 15-LOX-2.33 While Ca21-dependent mem-
brane binding by 5-LOX has been studied exten-
sively, mutations to the 5-LOX PLAT domain for
crystallization make it a poor model for describing
the Ca21-binding sites. However 11R-LOX, which
has an absolute requirement for membrane binding
for catalytic activity even in cell-free assays,11 was
crystallized in the absence of the cation and has
intact membrane binding loops. Both 15-LOX-2 and
the first 8R-LOX structure reported (2FNQ) have
intact Ca21-binding loops, and reveal density and
coordination geometry consistent with Ca21 binding.
The Ca21 ions appear to stabilize putative
membrane-insertion loops that emerge from the
edge of the amino terminal b-barrel. In Figure 7 the
structures of 15-LOX-2 and 8R-LOX (33% sequence
identity) with two and three Ca21 bound, respec-
tively, are superposed. Note the similarity in the
placement of the loops. While there is some devia-
tion in one loop, which could not be modeled in the
8R-structure, for the most part the loop regions of
the barrel are superposable. In contrast, a LOX pair
with greater sequence identity (47%) is superposed
in panel B. In this case, one structure in the absence
of Ca21 and the other in the presence. In this pair,
the loop structures are distinct. It seems reasonable
to infer from this comparison that binding of Ca21
may trigger a b-barrel loops conformational change
that favors membrane binding.
Given the clear modular structures of LOXs, the
question of whether the two domains can “flex”
about a hinge region has been raised. Small angle x-
ray scattering data are consistent with interdomain
movement in 15-LOX-1.46 However, to date no crys-
tal structure has revealed an alternate inter domain
packing or placement.
The Substrate Binding Cavity
Over the years individual LOX structures have led
to models for substrate recognition by this enzyme
family. A “boot-shaped” model was derived from the
inhibited 15-LOX structure reported in 199728 and
suggested that Ile-418, Phe-353 and Ile-593 define
cavity depth, and that Arg-403 tethered the sub-
strate carboxylate.28,47 Although, the “boot shaped”
Figure 7. Ca21 binding appears to promote structural changes in the loops of the PLAT domain. (A) Superposition of cartoon
renderings of 8R-LOX (light blue) and 15-LOX-2 structures (flesh), both in the presence of Ca21. Three Ca21 (spheres) sites are
found in the former, and two in the latter. (B) Superposition of 8R-LOX in the presence of Ca21 and 11-R-LOX in its absence.
Despite a higher sequence identity in this pair of LOX, the loop conformations are divergent, presumably a reflection of differen-
ces in the Ca21-bound- and Ca21-free states.
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model nicely explained the supporting mutagenesis
data, in retrospect it was incomplete due to what
was then interpreted as disordering of helix a2.28,29
Additionally, it was based on an inhibitor that lacks
the structural flexibility of arachidonic acid and so
might include conformational changes not required
for the natural substrate to enter.
Subsequently, the structure was reported of soy-
bean LOX-3 with the product 13-hydroperoxy-
octadecadienoic acid (13-HPODE) in a peroxy-iron
complex, the “purple lipoxygenase.”48 Purple LOX is
a transient intermediate formed by reaction of
excess hydroperoxide product with the enzyme, cap-
turing the iron in the ferric state.49 Remarkably this
induced little change in conformation of LOX-3 from
the native ferrous state.26,48 Experimental and com-
putational evidence indicates the purple complex is
not involved in the normal catalytic cycle,50 and
while the overall shape of the 13-HPODE is
substrate-like, its orientation in the active site does
not necessarily reflect substrate head-to-tail
orientation during catalysis. Despite this caveat, the
structure revealed that a boomerang-shaped polyun-
saturated fatty acid could be positioned, with mini-
mal protein conformational change, in the large
enclosed cavity that houses the catalytic iron.48
Currently, the structures of a (1) bacterial LOX
in complex with phospholipid,24 (2) the catalytic
domain of 12-LOX in complex with inhibitor,32
(3) 15-LOX-2 with a substrate mimic and finally,33
(4) an anaerobic structure of the aborted complex of
8R-LOX with arachidonic acid34 combine to provide
a robust structural context for understanding prod-
uct specificity and reveal a U-shaped cavity with
highly conserved Leu and Ile side chains to position
the pentadiene for attack. Since the substrates for
the plant enzyme have fewer double bonds, the cav-
ities are more boomerang in shape, but as expected,
the core of the active site is conserved throughout
the extensive LOX family.
Invariant Amino Acids Position the Pentadiene
for Attack
In the structure of the abortive complex of 8R-LOX
with arachidonic acid, obtained from crystals grown
in the absence of O2, the substrate is poised for
attack in the U-shaped cavity.34 The arched helix,
which lies above that catalytic iron and helps define
the active site cavity, contributes one of several
invariant leucines that line binding pocket. Leu-431
(invariant) and Ile-437 define the arch and make
contacts with the arachidonic acid: Leu-431 with the
central carbon of the pentadiene centered at C10
and Ile-437 at the top of the “U” between the car-
boxyl head (C1) and C17 at the tail. These amino
acids side chains fill the U from the side opposite
the catalytic iron, where just across from Leu-431
sits invariant Leu-627. Leu-627 and Leu-431 are
equidistant from the substrate, and the two side
chains appear to clamp the C10 pentadiene in place.
The base of the U is positioned by invariant Leu-385
on one side, and the Fe and His-384 and 2389 on
the other. Leu-385 and the catalytic iron cradle the
base of the “U” (Fig. 8).
Pocket depth, which allows the tail to slide in so
that C10 is attacked, appears to be conferred by Ala-
620, which with Ala-589 makes for a very a deep
cavity. Leu-381 and Val-428 define the wall of the
cavity at C15, and the polar and charged amino
acids Gln-380 and Asp-424 (highly conserved) flank
Figure 8. (A) The substrate adopts a horseshoe shape in the U-shaped channel (stereo). The side chains of highly conserved
amino acids line the base of the active site, along with Gly-427. Glu-430, part of an inter-helical charge cluster that includes the
substrate carboxylate, is shown in line rendering. The Fe21 (transparent rust sphere) is positioned behind the substrate. (B)
Detail of the superposition of inhibitors (rotated 180 with respect to (A)) observed in 15-LOX-2 (red) 12-LOX (gold C, red O)
and 15-LOX-1 (teal C, red O). The 15-LOX-2 and 12-LOX inhibitors conform to the arachidonic acid placement, while the 15-
LOX-1 inhibitor overlaps partially. The Fe21, solid rust sphere, is in front of the substrate in this view. An interactive view is
available in the electronic version of the article.
This figure also includes an iMolecules 3D interactive version that can be accessed via the link at the bottom of this figure’s caption.
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the cluster of histidines that hold the iron in place.
In the absence of substrate, Tyr-181 and Arg-182 of
helix a2 participate in an interhelical charge cluster
with Glu-430 of the arched helix. In the substrate-
bound structure, the fatty acid carboxylate expands
this charge network with only a slight (1.3 Å) out-
ward shift in the arched helix and the reorientation
of the side chain of Glu-430 to allow Arg-182 to
interact with the substrate carboxylate as well as
Glu-430.
While conserved/invariant amino acids line the
binding cavity, a counterpart for Arg-182, that is, a
neutralizing amino acid from helix a2, is not con-
served among LOXs. Yet this amino acid plays an
important role in positioning the polyunsaturated
fatty acid in a catalytically competent conformation
in the active site in 8R-LOX, as the mutation R182A
leads to profound substrate inhibition.34 Such an
observation suggests that arachidonic does indeed
enter the cavity in the absence of the neutralizing
amino acid, but van der Waals contacts alone (the
steric complementarity of the arachidonic acid and
the U-shaped active site) are not sufficient to
adequately fix the geometry of the pentadiene at the
catalytic iron in 8R-LOX (nonproductive binding).
The long hydrocarbon tail of the substrate makes
extensive contacts with the amino acid side chains
lining the site, but for 8R-LOX helix a2 must pro-
vide a polar/charged amino acid to interact with the
substrate carboxyl group, perhaps to prevent it from
penetrating deeper into the cavity, which extends
beyond C20 of the substrate. An anchoring residue
may not be necessary in all LOXs, especially those
with shallower cavities that do not require as much
“ease” built in to allow substrate entry and product
exit.
Reconciling the U-Shaped Active Sites that
Require Inverse Entry
To account for the product diversity among LOXs, a
wealth of experimental data has indicated that
LOXs differ with respect to which “end” of the sub-
strate is innermost. One can directly extrapolate
from the model of the 8R-enzyme with arachidonic
acid to the 15-LOX-2 and 12-LOX structures solved
with substrate mimics. Indeed, as one can see from
the superposition of arachidonic acid, the 15-LOX-2
and 12-LOX inhibitors [Fig. 8(b)], the 8R-LOX is
likely a robust, consensus model for substrate recog-
nition in these enzymes. In contrast, in order for 5-
LOX to produce the 5S- isomer of HPETE, the sub-
strate carboxyl must be innermost in the cavity.
Again, the 8R-model nicely explains this observation
as well. Take as an example 15-LOX-2 and 5-LOX,
two enzymes that differ in the direction of substrate
head-to-tail orientations. As one can see in the sche-
matic provided in Figure 9, given a cavity of equal
depth, if arachidonic acid enters “tail first” into the
cavity C15 is positioned at the site of oxygenation,
while head-first entry places C5 at this position.
Moreover, the product stereochemistries of 15S and
5S are a consequence of opposite faces of the sub-
strate aligning at the catalytic center. This sche-
matic predicts that 5-LOX and 15-LOX cavities are
of similar depth. As one can see from panel B, in
which the cavities of 15-LOX-2 and 5-LOX are
depicted with a U-shaped 15-LOX-2 inhibitor posi-
tioned as a substrate mimic, this is indeed the case.
Note the fork-like contour of the 5-LOX pocket
appears to be a perfect complement for a carboxyl
group. It is here where there is a His (600) in the 5-
LOX site, but a Val (603) in the 15-LOX-2 site. How-
ever recall that the active site in 5-LOX is “corked.”
Although the cavity depth is consistent of 5-LOX,
one must assume that the cavity is “uncorked” in
the active enzyme. Exactly what “uncorking”
involves is not clear, although a structure of an
“open” 5-LOX has been reported, the product of this
enzyme is not 5S-HPETE.51 In this structure a dra-
matic opening of the active site that results in a loss
of product specificity is revealed.
In Table II the counterparts of the amino acids
that line the 8R-LOX active site are given for all
LOX structures in the Protein Data Bank. Note the
invariant nature of many amino acids that envelop
the pentadiene to be attacked; this level of conserva-
tion is certainly not surprising given that the
enzymes share fundamental aspects of substrate rec-
ognition and catalysis. One hallmark of the plant
Figure 9. Inverse entry of substrate is consistent with cavity
depth in 15-LOX-2 and 5-LOX. (A) A schematic depicting
how the products 15S-HPETE and 5S-HPETE can be
explained by substrate entry in 15-LOX-2 as “tail-first” and
that in 5-LOX as “head-first.” (B) The cavity depths in 15-
LOX-2 (flesh) and 5-LOX (yellow) are consistent with this
interpretation. The innermost part of the 5-LOX cavity should
accommodate a carboxyl, rather than hydrocarbon.
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enzymes is the presence of Trp where nonplant
enzymes have a Leu. This Trp wedges right up
against the pentadiene to be attacked and at the
same time forms the proximal wall of a possible O2
access channel. This plant–specific sequence differ-
ence is coupled to a second substitution one turn far-
ther along the helix: another invariant Leu in the
animal enzymes is substituted by an Ala, presum-
ably to compensate for the added bulk of the Trp.
Interestingly, this second highly conserved amino
acid has been implicated in an O2 access pathway as
well in mammalian LOXs,21 as discussed in the fol-
lowing section.
Although the U-shaped model for the active site
is consistent with the inhibited structures of 12-LOX
and 15-LOX-2, it is not in agreement with the inhib-
ited 15-LOX-1 structure. Porcine 12-LOX and rabbit
15-LOX-1 share 80% identity and exhibit the same
overall U-shaped binding cavity described above in
8R-LOX. However, in apo-15-LOX-1 there is a con-
spicuous constriction of the internal end of the cav-
ity made by Phe-415 and Leu-597; both amino acids
are conserved in the porcine 12-LOX, and Leu-597 is
invariant. Indeed, the amino acids lining the active
site cavity are identical in the pair. Both enzymes
have product stereochemistry consistent with tail-
first entry, but the porcine 12-LOX cavity can allow
the arachidonic acid to slide in deep enough to posi-
tion the pentadiene centered at C10. Although the
rabbit enzyme does produce the 12S isomer, the
bulk of the product is 15S (1:9 ratio). Why do these
highly homologous enzymes have different product
profiles? This may due to the obvious constriction
15-LOX-1, which must be reconfigured to allow sub-
strate entry and positioning of the C13 pentadiene.
As mentioned above, the crystal structure of 15-
LOX-1 with the inhibitor RS7 revealed a 10 Ang-
strom displacement of a2, and this structure has
been used a template for models of 15-LOX-1 in com-
plex with substrate. While it is clear that due to the
constriction a conformational change must occur in
the enzyme for substrate to fully enter the active
site, whether arachidonic acid binding induces the
RS7-induced conformational change in 15-LOX-1 is
not clear. The highly homologous 12-LOX does not
require displacement of a2 for its inhibitor, which
adopts a U-like structure, to occupy the site. It is
possible that the RS7 conformation is unique to the
inhibitor, which is constrained in a conformation
inconsistent with the U-shaped cavity.
An Oxygen Access Pathway
Common to LOX structures is a long tubular open-
ing that emanates from the base of the U-shaped
cavity. The tubular opening and active site iron lie
on opposite sides of the substrate, as observed in the
substrate bound 8R-LOX structure. Minor et al.25
first described this possible O2 channel, bounded by
Trp-500 and Ile-553 in the 1.4 Å resolution structure
of Soybean LOX L1 and experiments by Klinman
and colleagues18,19 supported a role for Ile553 in
controlling O2 access in that enzyme.
Subsequently, Coffa and Brash16,17 described a
Gly/Ala “switch” that impacts product stereochemis-
try. 8R- and 11R- enzymes have a Gly at this resi-
due, while the 12S- 15S- and 5S- enzymes all have
Ala. One way to think about this “switch” is that it
directs O2 to the carbon which is either 12 or 22
from the central carbon of the attacked pentadiene
and thus the Gly/Ala switch nudges the channel
toward the substrate carbon that will carry the per-
oxide group.
In a computational approach with the 15-LOX,
Saam et al. identified the counterpart of 8R-LOX
Leu-390(Leu-367 in the 15-LOX-1 enzyme) as criti-
cal in controlling O2 access. According to sequence
analysis with Evolutionary Trace52 Leu-390 is invar-
iant in animal LOXs and lies one helical turn from
the animal LOX invariant active site Leu-385 in 8R-
LOX. Leu-385 is the animal counterpart of Trp-500,
which helps define the O2 channel in Soybean
LOX1. Thus in plants a Trp-Ala pair define one wall
of the O2 channel, and it animal LOX it is a Leu-
Leu pair. The spatial relationship among these
channel-defining amino acids is depicted in the
structure of the abortive complex of 8R-LOX with
substrate (Fig. 10). In 8R-LOX, the channel provides
Figure 10. A possible O2 access channel intersects with the
U-shaped cavity on the side opposite the catalytic iron in 8R-
LOX. Amino acids which have been shown to control O2
access in other LOXs are in included. Soybean LOX1 side
chains (green) are Ile-553, Ala-542 (the Gly/Ala switch), Trp-
500 and Ala-505. Leu-385 and Leu-390 are the animal coun-
terparts of the Trp-Ala pair in plants.
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direct access to the enzyme surface. This is not the
case for LOXs in general, and the full path that
molecular oxygen must travel to reach the substrate
is not obvious.
Conclusions
As is commonly observed in protein families, minor
modifications on a conserved structural framework
can correlate with essential functional differences
among family members. LOX structures have
revealed a highly conserved Fe-coordination sphere
positioned in a helical core. A hydrophobic U-shaped
channel that can accommodate the polyunsaturated
fatty acid substrate lies adjacent to the active site
iron, with the metal ion positioned roughly at the
base of the U. The invariant Leucines that line the
base of the U appear to clamp a substrate penta-
diene in place for hydrogen abstraction. Also at the
base of the U, but on the opposite side of the sub-
strate, is a putative O2 access cavity. Amino acids
peripheral to this invariant core determine which
pentadiene is aligned at the active site in the indi-
vidual LOXs, as well head-to-tail positioning of the
substrate. These features confer elegantly simple
variations on a theme: a highly conserved core
active site with alternate orientations for their com-
mon substrates, so that each enzyme generates a
distinct product.
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